The oral form of semaglutide effectively reduces blood sugar levels, but weight loss may be less pronounced than injectable forms
These type 2 diabetes weight loss injections offer a dual benefit, helping to manage blood sugar while promoting significant weight reduction
Your thoughts and feedback are invaluable to us as we endeavor to provide informative and insightful content in our future spotlights
These indication-specific regimens are relevant for mechanistic interpretation, because higher dose exposure and differing baseline metabolic states in obesity-focused cohorts may yield larger weight-loss responses and distinct endpoint profiles compared with T2DM trials, where glycemic control and diabetes-related outcomes represent primary targets
A yield that will not fund retirement
Understanding the mechanisms of action and clinical effects of these medications on skeletal muscle will enable more nuanced and informed choices of agent for those with T2DM and sarcopenia, but importantly may also suggest novel therapeutic avenues to prevent and treat sarcopenia in patients who do not have T2DM
